Erythropoietin therapy for anemic patients with non-small cell lung cancer in combination chemotherapy
- VernacularTitle:促红细胞生成素治疗晚期非小细胞肺癌化疗所致的贫血
- Author:
Zhaoxia WANG
;
Weijian SHI
;
Keming WANG
- Publication Type:Journal Article
- Keywords:
erythropoietin;
non-small-cell lung cancer;
chemotheraphy induced anemia
- From:China Oncology
1998;0(04):-
- CountryChina
- Language:Chinese
-
Abstract:
150 g/L, the dose of EPO was decreased by half. The control group consisted of 20 patients given Leucogenum, the dose was 20 mg every time, 3 times per day. Results: From the fourth week after therapy, the Hb, HCT, RBC of the EPO treatment group was significantly higher than prior to treatment( P
